<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Liver-Disease on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/liver-disease/</link><description>Recent content in Liver-Disease on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Wed, 13 May 2026 10:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/liver-disease/index.xml" rel="self" type="application/rss+xml"/><item><title>Clinical conditions associated with a high ANA titer in non-autoimmune individuals</title><link>https://rheumatologydigest.org/posts/high-ana-titer-non-autoimmune/</link><pubDate>Wed, 13 May 2026 10:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/high-ana-titer-non-autoimmune/</guid><description>In a 28,781-patient EMR phenome-wide study, a high ANA titer (≥1:640) without autoimmune disease was strongly enriched for non-AI liver disease (NAFLD/NASH, alcohol-related) and metabolic comorbidity — broadening the differential for an unexplained high-titer ANA beyond the usual autoimmune workup.</description></item></channel></rss>